WAYNE, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced today that it has completed the previously announced acquisition of Z-Medica, LLC, an industry-leading manufacturer of hemostatic products. On October 28, 2020, Teleflex announced a definitive agreement to acquire Z-Medica. Under the […]
Financial
MicroVention, Inc. Files Trade Secret Lawsuit Against Balt USA, LLC
ALISO VIEJO, Calif., Dec. 23, 2020 /PRNewswire/ — MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the filing of a second lawsuit against Balt USA, LLC and four former employees for trade secret misappropriation. This lawsuit follows an earlier patent lawsuit filed against Balt USA in July 2019 that is ongoing. […]
The Children’s Heart Foundation funds new congenital heart defect research
Since 1996, the Foundation has funded nearly $14 million in research on congenital heart defects–America’s most common birth defect. NORTHBROOK, Ill., Dec. 22, 2020 /PRNewswire/ — The Children’s Heart Foundation, the nation’s leading organization dedicated to funding congenital heart defect (CHD) research, will fund over $735,000 in CHD research and scientific collaborations this year across […]
Atriomx Health Announces $10 Million Series A Financing
MENLO PARK, Calif., Dec. 22, 2020 /PRNewswire/ — Atriomx Health, a Menlo Park, California-based developer of novel, non-invasive solutions for the detection and characterization of the underlying disease mechanisms of atrial fibrillation and other arrhythmias, announced today that it has secured a $10 million Series A financing. Ajax Health and Zeus Health will co-lead the Series […]
4C Medical Technologies Announces Completion of a $10 Million Over-Subscribed Convertible Note Financing
MINNEAPOLIS, Dec. 22, 2020 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a privately-held medical technology company focused on the development of minimally invasive technologies for structural heart disease, today announced it has completed an over-subscribed convertible note financing in which it has raised $10 million in gross proceeds. The financing was led by a China-based […]
Ontrak Announces Closing of Follow-On Offering of Non-Convertible Preferred Stock
Company to use non-dilutive capital for working capital, M&A, investment in technology SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK, OTRKP) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized healthcare company, today announced that it has closed its previously announced underwritten public offering of 1,730,000 shares of its 9.50% Series […]
Philips to become a global leader in patient care management solutions for the hospital and the home through the acquisition of BioTelemetry, Inc.
Philips to acquire BioTelemetry, Inc. for USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion) Acquisition is a strong fit with Philips’ strategy to transform the delivery of healthcare: combination of Philips’ leading patient monitoring position in the hospital with BioTelemetry’s leading cardiac diagnostics […]
Advanced Bifurcation Systems Announces First Closing of Series A Financing
LIVERMORE, Calif., Dec. 16, 2020 /PRNewswire/ — Advanced Bifurcation Systems, Inc. (ABS), a Livermore, CA-based maker of the ABS System, a proprietary stent delivery system that is specifically designed to efficiently treat coronary bifurcation lesions, is pleased to announce the first closing of an $11 million Series A equity financing. The round was led by […]
Cardurion Pharmaceuticals Announces Appointment of Howard K. Surks, M.D., as Chief Scientific Officer and Head, Translational Medicine
Appointment reflects progress of Company’s early-stage pipeline toward the clinic BOSTON–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced the appointment of Howard K. Surks, M.D., as chief scientific officer and […]
Analytics 4 Life® Rebrands as CorVista® Health; Appoints Scott Burger as Chief Commercial Officer and Vice President
Company Advancing Proprietary Machine Learning to Improve Care in Cardiology TORONTO–(BUSINESS WIRE)–Analytics 4 Life today announced the appointment of Scott Burger to Chief Commercial Officer and Vice President. Scott will lead the commercialization efforts of the CorVista® System, a non-invasive point-of-care solution that allows physicians to rapidly assess heart function. […]
Recent
Popular
- No commented posts yet